Takeda financials show growth as post-Weber era looms

Japanese drugmaker Takeda’s (TYO: 4502) latest financial results were presented Thursday, though they took a back seat to the news that the group’s long-term chief executive Christophe Weber is to retire in 2026.

He has been credited with leading a major transformation in his 12-year reign at Takeda, which has announced results after the third quarter of Japan’s financial year, along with forecasts for the year as a whole.

Revenue for the first three quarters grew by nearly 10% to 3,528.2 billion yen ($22.83 billion), while operating profit for the nine-month period was 417.5 billion yen, up 86%.